BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32313942)

  • 1. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
    Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
    Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer.
    Cheng YW; Zeng FM; Li DJ; Wang SH; He JZ; Guo ZC; Nie PJ; Wu ZY; Shi WQ; Wen B; Xu XE; Liao LD; Li ZM; Wu JY; Zhan J; Zhang HQ; Chang ZJ; Zhang K; Xu LY; Li EM
    Cancer Commun (Lond); 2021 Dec; 41(12):1398-1416. PubMed ID: 34555274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
    Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
    Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
    Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1α.
    Tian B; Liu J; Zhang N; Song Y; Xu Y; Xie M; Wang B; Hua H; Shen Y; Li Y; Yang M
    Oncogene; 2021 May; 40(21):3734-3747. PubMed ID: 33941854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
    Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
    Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
    Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
    Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 9. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma.
    Wang C; Cheng L; Song S; Wu S; Sun G
    J Cell Physiol; 2020 Nov; 235(11):8224-8235. PubMed ID: 31957872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
    Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
    Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P300-dependent acetylation of histone H3 is required for epidermal growth factor receptor-mediated high-mobility group protein A2 transcription in hepatocellular carcinoma.
    Liang C; Niu J; Wang X; Zhang ZS; Yang RH; Yao X; Liu FY; Li WQ; Pei SH; Sun H; Wang CJ; Fang D; Xie SQ
    Cancer Sci; 2021 Feb; 112(2):679-690. PubMed ID: 33164305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
    Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
    Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway.
    Li P; Chen X; Qin G; Yue D; Zhang Z; Ping Y; Wang D; Zhao X; Song M; Zhao Q; Li J; Liu S; Wang D; Zhang C; Lian J; Cao L; Li F; Huang L; Wang L; Yang L; Huang J; Li H; Zhang B; Zhang Y
    Cancer Immunol Res; 2018 Oct; 6(10):1246-1259. PubMed ID: 30082413
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.